Estarylla Kit
Product Images NDC 70700-119

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Estarylla (NDC 70700-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chart

This text describes different methods of birth control and the number of pregnancies per 100 women in a year for each method. It includes information about hormonal contraceptives such as birth control pills, skin patches, and vaginal rings, as well as non-hormonal methods such as condoms, diaphragms, and spermicides. It also mentions long-acting methods such as injections, intrauterine devices, and sterilization. Finally, it suggests natural methods such as avoiding sex during the most fertile days of the monthly cycle or using the withdrawal method.*

FDA Label Image

Estarylla-blister (Estarylla Blister)

FDA Label Image

Estarylla-carton (Estarylla Carton)

This is a prescription information for Estarylla tablet. It contains 21 blue and 7 green tablets which have to be taken one after the other for 28 days. The dosage must be taken as per the prescribed schedule. The package contains three units of blister cards each having 28 tablets. The prescription also includes essential details like the manufacturer, dosage, and ingredients of the tablet.*

FDA Label Image

Figure 2

This appears to be a list of studies focused on women's contraceptive use, including the year of the study, whether it focused on ever use or current use, and the corresponding Effect Estimate expressed as OR/RR. However, there is not enough context to provide any additional information or meaningful interpretation of the results.*

FDA Label Image

Structure Ee

Ethinyl Estradiol is a synthetic estrogen used in combination with progestin as an oral contraceptive. It prevents ovulation by inhibiting the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus and therefore prevents the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland. This hormone is also used for the treatment of postmenopausal osteoporosis, prostate cancer, and breast cancer.*

FDA Label Image

Structure Norgestimate

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.